Publication | Closed Access

Ginsenoside Rg3 enhances the chemosensitivity of tumors to cisplatin by reducing the basal level of nuclear factor erythroid 2-related factor 2-mediated heme oxygenase-1/NAD(P)H quinone oxidoreductase-1 and prevents normal tissue damage by scavenging cisplatin-induced intracellular reactive oxygen species

Tumor BiologyBasal LevelH Quinone Oxidoreductase-1MedicinePharmacologyCell DeathGinsenoside Rg3Cancer BiologyTumor SuppressorOncologyCell BiologyRedox BiologyTumor MicroenvironmentCancer ResearchOxidative Stress